Striatal amyloid is associated with tauopathy and memory decline in familial Alzheimer’s disease

zu Verbundenen Objekten

Standort
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1758-9193
Umfang
Online-Ressource
Sprache
Englisch
Anmerkungen
online resource.

Erschienen in
Striatal amyloid is associated with tauopathy and memory decline in familial Alzheimer’s disease ; volume:11 ; number:1 ; day:4 ; month:2 ; year:2019 ; pages:1-6 ; date:12.2019
Alzheimer's research & therapy ; 11, Heft 1 (4.2.2019), 1-6, 12.2019

Urheber
Hanseeuw, Bernard J.
Lopera, Francisco
Sperling, Reisa A.
Norton, Daniel J.
Guzman-Velez, Edmarie
Baena, Ana
Pardilla-Delgado, Enmanuelle
Schultz, Aaron P.
Gatchel, Jennifer
Jin, David
Chen, Kewei
Reiman, Eric M.
Johnson, Keith A.
Quiroz, Yakeel T.
Beteiligte Personen und Organisationen
SpringerLink (Online service)

DOI
10.1186/s13195-019-0468-1
URN
urn:nbn:de:101:1-2019031000152593941279
Rechteinformation
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
14.08.2025, 10:53 MESZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Original beim Datenpartner anzeigen

Beteiligte

  • Hanseeuw, Bernard J.
  • Lopera, Francisco
  • Sperling, Reisa A.
  • Norton, Daniel J.
  • Guzman-Velez, Edmarie
  • Baena, Ana
  • Pardilla-Delgado, Enmanuelle
  • Schultz, Aaron P.
  • Gatchel, Jennifer
  • Jin, David
  • Chen, Kewei
  • Reiman, Eric M.
  • Johnson, Keith A.
  • Quiroz, Yakeel T.
  • SpringerLink (Online service)

Ähnliche Objekte (12)

Untangling the Tauopathy for Alzheimer’s disease and parkinsonism

Untangling the Tauopathy for Alzheimer’s disease and parkinsonism

Familial Alzheimer’s Disease and Recessive Modifiers

Familial Alzheimer’s Disease and Recessive Modifiers

Quantitative detection and staging of presymptomatic cognitive decline in familial Alzheimer’s disease: a retrospective cohort analysis

Quantitative detection and staging of presymptomatic cognitive decline in familial Alzheimer’s disease: a retrospective cohort analysis

Associations of Alzheimer’s disease risk variants with gene expression, amyloidosis, tauopathy, and neurodegeneration

Associations of Alzheimer’s disease risk variants with gene expression, amyloidosis, tauopathy, and neurodegeneration

Fazekas scale magnetic resonance imaging assessment in Alzheimer’s disease and primary age-related tauopathy

Fazekas scale magnetic resonance imaging assessment in Alzheimer’s disease and primary age-related tauopathy

Selective ferroptosis vulnerability due to familial Alzheimer’s disease presenilin mutations

Selective ferroptosis vulnerability due to familial Alzheimer’s disease presenilin mutations

α-Secretase nonsense mutation (ADAM10 Tyr167*) in familial Alzheimer’s disease

α-Secretase nonsense mutation (ADAM10 Tyr167*) in familial Alzheimer’s disease

Molecular analysis of Small Vessel Disease in Familial Alzheimer’s Disease

Molecular analysis of Small Vessel Disease in Familial Alzheimer’s Disease

Awareness of Olfactory Dysfunction in Subjective Cognitive Decline, Mild Cognitive Decline, and Alzheimer’s Disease

Awareness of Olfactory Dysfunction in Subjective Cognitive Decline, Mild Cognitive Decline, and Alzheimer’s Disease

Identification of tauopathy-associated lipid signatures in Alzheimer’s disease mouse brain using label-free chemical imaging

Identification of tauopathy-associated lipid signatures in Alzheimer’s disease mouse brain using label-free chemical imaging

Longitudinal measurement of serum neurofilament light in presymptomatic familial Alzheimer’s disease

Longitudinal measurement of serum neurofilament light in presymptomatic familial Alzheimer’s disease

Neuroimaging advances regarding subjective cognitive decline in preclinical Alzheimer’s disease

Neuroimaging advances regarding subjective cognitive decline in preclinical Alzheimer’s disease

Verbundene Objekte